GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $469,000 | +4.9% | 10,764 | +4.8% | 0.16% | +25.0% |
Q1 2022 | $447,000 | -0.9% | 10,272 | +0.4% | 0.12% | +5.1% |
Q4 2021 | $451,000 | +15.6% | 10,230 | +4.5% | 0.12% | -21.9% |
Q2 2021 | $390,000 | +12.1% | 9,790 | +0.4% | 0.15% | +58.9% |
Q1 2021 | $348,000 | -3.1% | 9,748 | +0.0% | 0.10% | -6.9% |
Q4 2020 | $359,000 | -1.1% | 9,744 | +0.9% | 0.10% | -15.7% |
Q3 2020 | $363,000 | -10.6% | 9,653 | -3.1% | 0.12% | -22.9% |
Q2 2020 | $406,000 | +2.0% | 9,959 | -5.3% | 0.16% | -15.1% |
Q1 2020 | $398,000 | -24.5% | 10,516 | -6.2% | 0.18% | +1.1% |
Q4 2019 | $527,000 | +7.6% | 11,207 | -2.4% | 0.18% | +11.6% |
Q3 2019 | $490,000 | +7.0% | 11,478 | +0.3% | 0.16% | -3.0% |
Q2 2019 | $458,000 | -4.0% | 11,447 | +0.3% | 0.17% | -7.1% |
Q1 2019 | $477,000 | +9.7% | 11,410 | +0.3% | 0.18% | -24.2% |
Q4 2018 | $435,000 | – | 11,378 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |